aTyr Pharma (ATYR)

• Market cap: $66.7M
• 1 day: -9.69%
• 5 days: -13.18%
• 1 month: -33.31%
• 3 months: -86.15%
• 6 months: -80.23%
• Year to date: -82.6%
• 1 year: -77.4%
• 5 years: -79.2%
• 10 years: -99.51%
• Sector: Healthcare
• Industry: Biotechnology

About: aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Employees: 59